Latest Expert Opinions

Signal
Opinion
Expert
COMMENT
COMMENT
January 4, 2017

The stock has gone down because of fears of its patent protection on one of its very big products Copaxon, and he thinks the stock is really undervalued at this time, simply because it trades in about 120 countries globally with generic product. No matter what happens with the American Affordable Care Act, generic pharmaceuticals are the wave of the future, and this company is likely to go back up and claim the highs of a couple of years ago.

The stock has gone down because of fears of its patent protection on one of its very big products Copaxon, and he thinks the stock is really undervalued at this time, simply because it trades in about 120 countries globally with generic product. No matter what happens with the American Affordable Care Act, generic pharmaceuticals are the wave of the future, and this company is likely to go back up and claim the highs of a couple of years ago.

David Baskin
President, Baskin Wealth Management
Price
$37.740
Owned
Yes
DON'T BUY
DON'T BUY
January 4, 2017

He wouldn’t buy at this point. There is a lot of uncertainty going on. The habits of millennials are very different from the habits of the previous generation.

He wouldn’t buy at this point. There is a lot of uncertainty going on. The habits of millennials are very different from the habits of the previous generation.

David Baskin
President, Baskin Wealth Management
Price
$13.080
Owned
No
COMMENT
COMMENT
January 4, 2017

This is a stock that got absolutely killed in 2015, and had a tremendous resurgence last year. In general, he likes the protein stocks. This is inexpensive, and still has an acquisition strategy which it is trying to play out. Good company.

High Liner Foods (HLF-T)
January 4, 2017

This is a stock that got absolutely killed in 2015, and had a tremendous resurgence last year. In general, he likes the protein stocks. This is inexpensive, and still has an acquisition strategy which it is trying to play out. Good company.

David Baskin
President, Baskin Wealth Management
Price
$19.310
Owned
Unknown
COMMENT
COMMENT
January 4, 2017

This has a balance sheet that is very highly levered. The risk, of course, is that interest rates go up, which pummels earnings. At the same time, because this is regulated, when interest rates go up, the regulatory authorities tend to allow them to increase rates faster.

Enbridge (ENB-T)
January 4, 2017

This has a balance sheet that is very highly levered. The risk, of course, is that interest rates go up, which pummels earnings. At the same time, because this is regulated, when interest rates go up, the regulatory authorities tend to allow them to increase rates faster.

David Baskin
President, Baskin Wealth Management
Price
$57.040
Owned
Unknown
COMMENT
COMMENT
January 4, 2017

Hopes the company succeeds and that it survives. Its balance sheet is a smoldering crater. They have a huge amount of debt. He has no idea if this company is going to make any money on its airplane orders. He worries that they are filling up the order book because they need to show some activity and they aren’t going to make any money on these planes. They’ve never made much money in the train business. You have negative shareholder equity in this company. There is a huge amount of debt that has to be refinanced. He doesn’t see how this company digs itself out of the hole.

Hopes the company succeeds and that it survives. Its balance sheet is a smoldering crater. They have a huge amount of debt. He has no idea if this company is going to make any money on its airplane orders. He worries that they are filling up the order book because they need to show some activity and they aren’t going to make any money on these planes. They’ve never made much money in the train business. You have negative shareholder equity in this company. There is a huge amount of debt that has to be refinanced. He doesn’t see how this company digs itself out of the hole.

David Baskin
President, Baskin Wealth Management
Price
$2.410
Owned
Unknown
PARTIAL SELL
PARTIAL SELL
January 4, 2017

This has always kind of traded in sympathy with oil, but the supply and demand dynamics of methane are quite separate from oil. The stock got killed because there is too much capacity. No new capacity has come online, and prices have been very strong in the last little while. He got out of this because he felt he couldn’t predict methanol prices. However, methanol is the base chemical for a lot of industrial chemicals and is needed for those processes. If he owned it, he would be taking some profits on it.

Methanex Corp (MX-T)
January 4, 2017

This has always kind of traded in sympathy with oil, but the supply and demand dynamics of methane are quite separate from oil. The stock got killed because there is too much capacity. No new capacity has come online, and prices have been very strong in the last little while. He got out of this because he felt he couldn’t predict methanol prices. However, methanol is the base chemical for a lot of industrial chemicals and is needed for those processes. If he owned it, he would be taking some profits on it.

David Baskin
President, Baskin Wealth Management
Price
$61.070
Owned
No
COMMENT
COMMENT
January 4, 2017

He is a believer in this company, both the stores and the home delivery product, and believes that the stock will come back.

CVS Health Corp (CVS-N)
January 4, 2017

He is a believer in this company, both the stores and the home delivery product, and believes that the stock will come back.

David Baskin
President, Baskin Wealth Management
Price
$79.750
Owned
Yes